Background and Objectives: Polydeoxyribonucleotides (PDRN), composed of DNA fragments derived from salmon DNA, is widely recognized for its regenerative properties. It has been extensively used in medical applications, such as dermatology and wound healing, due to its ability to enhance cellular metabolic activity, stimulate angiogenesis, and promote tissue regeneration. In the field of dentistry, PDRN has shown potential in promoting periodontal healing and bone regeneration. This study aims to investigate the effects of PDRN on the morphology, survival, and osteogenic differentiation of gingiva-derived stem cell spheroids, with a focus on its potential applications in tissue engineering and regenerative dentistry. Materials and Methods: Gingiva-derived mesenchymal stem cells were cultured and formed into spheroids using microwells. The cells were treated with varying concentrations of PDRN (0, 25, 50, 75, and 100 μg/mL) and cultivated in osteogenic media. Cell morphology was observed over seven days using an inverted microscope, and viability was assessed with Live/Dead Kit assays and Cell Counting Kit-8. Osteogenic differentiation was evaluated by measuring alkaline phosphatase activity and calcium deposition. The expression levels of osteogenic markers RUNX2 and COL1A1 were quantified using real-time polymerase chain reaction. RNA sequencing was performed to assess the gene expression profiles related to osteogenesis. Results: The results demonstrated that PDRN treatment had no significant effect on spheroid diameter or cellular viability during the observation period. However, a PDRN concentration of 75 μg/mL significantly enhanced calcium deposition by Day 14, suggesting increased mineralization. RUNX2 and COL1A1 mRNA expression levels varied with PDRN concentration, with the highest RUNX2 expression observed at 25 μg/mL and the highest COL1A1 expression at 75 μg/mL. RNA sequencing further confirmed the upregulation of genes involved in osteogenic differentiation, with enhanced expression of RUNX2 and COL1A1 in PDRN-treated gingiva-derived stem cell spheroids. Conclusions: In summary, PDRN did not significantly affect the viability or morphology of gingiva-derived stem cell spheroids but influenced their osteogenic differentiation and mineralization in a concentration-dependent manner. These findings suggest that PDRN may play a role in promoting osteogenic processes in tissue engineering and regenerative dentistry applications, with specific effects observed at different concentrations.

Background: This study aimed to conduct a meta-analysis to assess the differences in the performance of root coverage between collagen matrix and subepithelial connective tissue. Methods: A comprehensive search using a combination of controlled vocabulary (MeSH) and free-text terms was undertaken by two reviewers to identify published systematic reviews. Three major electronic databases (Medline via PubMed, Cochrane database, and Embase) were searched up to October 2023. Results: Initially, five hundred and seventy-six articles were identified, but only nine studies met the criteria for inclusion in the meta-analysis. Meta-analysis showed that the pooled mean difference in mean root coverage of collagen matrix compared with subepithelial connective tissue was −0.48 (95% confidence interval of −0.69 to −0.26). The relative risk of complete root coverage of collagen matrix compared with subepithelial connective tissue was 0.68 (95% confidence interval, 0.49 to 0.94). The pooled mean difference in width of keratinized tissue of collagen matrix compared with subepithelial connective tissue was −0.75 (95% confidence interval of −1.25 to −0.26). Conclusions: The outcomes of this study revealed that subepithelial connective tissue generally exhibited superior performance. Nonetheless, the utilization of the coronally advanced flap with collagen matrix may yield comparable results in terms of the percentage of complete root coverage.

Background and Objectives: Tacrolimus is a macrolide lactone compound derived from the bacterium Streptomyces tsukubensis, widely known as an immunosuppressant. In basic research, the effects of tacrolimus on osteogenic differentiation have been tested using mesenchymal stem cells. In this study, tacrolimus’s effects on the cellular survival and osteogenic differentiation of stem cell spheroids were investigated. Materials and Methods: Concave microwells were used to form stem cell spheroids in the presence of tacrolimus at final concentrations of 0 μg/mL, 0.1 μg/mL, 1 μg/mL, 10 μg/mL, and 100 μg/mL. A microscope was used to test cellular vitality qualitatively, and an assay kit based on water-soluble tetrazolium salt was used to measure cellular viability quantitatively. Alkaline phosphatase activity and an anthraquinone dye test for measuring calcium deposits were used to assess osteogenic differentiation. To assess the expression of osteogenic differentiation, a quantitative polymerase chain reaction, Western blot, and RNA sequencing were performed. Results: Spheroids across all concentrations maintained a relatively uniform and spherical shape. Cell viability assay indicated that tacrolimus, up to a concentration of 100 μg/mL, did not significantly impair cell viability within spheroids cultured in osteogenic media. The increase in calcium deposition, particularly at lower concentrations of tacrolimus, points toward an enhancement in osteogenic differentiation. There was an increase in COL1A1 expression across all tacrolimus concentrations, as evidenced by the elevated mean and median values, which may indicate enhanced osteogenic activity. Conclusions: This study showed that tacrolimus does not significantly impact the viability of stem cell spheroids in osteogenic media, even at high concentrations. It also suggests that tacrolimus may enhance osteogenic differentiation, as indicated by increased calcium deposition and COL1A1 expression. These findings advance our understanding of tacrolimus’s potential roles in tissue repair, regeneration, and stem cell-based therapeutic applications.

Background and Objectives: Mesenchymal stem cells hold promise for tissue regeneration, given their robust growth and versatile differentiation capabilities. An analysis of bone marrow-sourced mesenchymal stem cell proliferation showed that 17β-estradiol could enhance their growth. This study aims to investigate the influence of 17β-estradiol on the shape, survival, osteogenic differentiation, and mineralization of human mesenchymal stem cells. Materials and Methods: Spheroids made from human gingiva-derived stem cells were cultivated with varying concentrations of 17β-estradiol: 0, 0.01, 0.1, 1, and 10 nM. Morphology was assessed on days 1, 3, and 5. The live/dead kit assay was employed on day 3 for qualitative cell viability, while cell counting kit-8 was used for quantitative viability assessments on days 1, 3, and 5. To evaluate the osteogenic differentiation of the spheroids, a real-time polymerase chain reaction assessed the expressions of RUNX2 and COL1A1 on day 7. Results: The stem cells formed cohesive spheroids, and the inclusion of 17β-estradiol did not noticeably alter their shape. The spheroid diameter remained consistent across concentrations of 0, 0.01, 0.1, 1, and 10 nM of 17β-estradiol. However, cellular viability was boosted with the addition of 1 and 10 nM of 17β-estradiol. The highest expression levels for RUNX2 and COL1A1 were observed with the introduction of 17β-estradiol at 0.1 nM. Conclusions: In conclusion, from the results obtained, it can be inferred that 17β-estradiol can be utilized for differentiating stem cell spheroids. Furthermore, the localized and controlled use, potentially through localized delivery systems or biomaterials, can be an area of active research. While 17β-estradiol holds promise for enhancing stem cell applications, any clinical use requires a thorough understanding of its mechanisms, careful control of its dosage and delivery, and extensive testing to ensure safety and efficacy.

Background: A number of mechanical decontamination methods have been proposed, however, there is no agreed-upon gold standard among them. This study aims to conduct a meta-analysis to assess the differences in the management of an inflammatory reaction around dental implants between air abrasion and mechanical decontamination. Methods: A comprehensive search strategy was employed, incorporating controlled vocabulary (MeSH) and free-text terms. This search was conducted by two reviewers to identify published systematic reviews. Three major electronic databases, namely, Medline via PubMed, the Cochrane database, and Embase, were searched up to May 2024. Results: Initially, 300 articles were identified. After conducting a comprehensive search and applying strict inclusion criteria, a total of 13 studies were deemed eligible for inclusion in the meta-analysis. The results showed that the mean difference in probing depth between air abrasion and other mechanical decontamination was 0.28 (95% confidence interval, −0.20 to 0.76). The mean difference in probing depth of air abrasion compared with other mechanical decontamination in maintenance purposes was 1.05 (95% confidence interval, 0.18 to 1.91). The mean difference in bleeding on probing between air abrasion and other mechanical decontamination was 0.51 (95% confidence interval, 0.07 to 0.95). The mean difference in alveolar bone loss between air abrasion and other mechanical decontamination was −0.14 (95% confidence interval, −0.77 to 0.48). The mean difference in alveolar bone loss for surgical approaches of air abrasion compared with other mechanical decontamination was 0.32 (95% confidence interval, 0.03 to 0.61). Conclusions: The findings of the study indicate that the use of air abrasion was just as effective as other mechanical decontamination methods in reducing probing depth and alveolar bone loss. The subgroup analysis showed that air abrasion was less effective in reducing probing depth in maintenance purposes. Additionally, air abrasion was less effective in reducing alveolar bone loss in surgical approaches.

Enamel matrix derivative (EMD) has been proposed as an adjunctive treatment for peri-implantitis, a prevalent complication of dental implants characterized by inflammatory responses and progressive bone loss around the implant site. This study aimed to perform a systematic review and meta-analysis to evaluate the efficacy of EMD compared with control interventions in the treatment of peri-implantitis. A comprehensive literature search was conducted by two independent reviewers using a combination of Medical Subject Headings (MeSHs) and free-text terms. The search included three major electronic databases—Medline via PubMed, the Cochrane Library, and Embase—and studies published up to November 2024. The search aimed to identify relevant clinical trials assessing the long-term outcomes of EMD in peri-implantitis treatment. Out of an initial 54 articles identified, five met the inclusion criteria and were included in the meta-analysis. The pooled mean difference for probing depth reduction with EMD compared to controls was 0.88 (95% confidence of interval (CI): −1.26 to 2.02). The decrease in bleeding on probing yielded a pooled mean difference of 16.70 (95% CI: −4.93 to 38.32). For bone level gain, the pooled mean difference was 0.59 (95% CI: −0.01 to 1.19). This meta-analysis indicated that the most significant improvement with the use of EMD was observed in bone level gain with surgical approach. Moreover, the adjunctive use of EMD in the treatment of peri-implantitis may offer clinical benefits in reducing probing depth and bleeding on probing at the three-month evaluation. These findings support the consideration of EMD as a valuable adjunct in peri-implantitis treatment protocols, warranting further investigation through well-designed, long-term randomized controlled trials.